Vaccines vs variants: the race to immunise the developing world


Vaccines vs variants: the race to immunise the developing world

Spread of new Covid strains has made it even more urgent to launch rapid vaccination drives in poorer countries

David Pilling, Stephanie Findlay and Bryan Harris

On a balmy day in January on the outskirts of Pune, a city of three million people in Maharashtra state, women in saris are sitting on plastic chairs under a humming fan waiting for their first shot of Covishield as the Oxford/AstraZeneca Covid-19 vaccine is known in India.

Wearing a white doctor’s coat, Dr Varsha Gaekwad, who is overseeing the first immunisations of frontline healthcare workers in the country of nearly 1.4 billion people, says it will take time for the general public to gain confidence in the vaccine. “Once the health workers are going ahead with it, that means it’s 100% safe,” she says. “That is what the community will see.”

Little in the peaceful and orderly scene in Pune hints at the historic significance of what is, in its small way, the start of the biggest vaccination campaign in human history. As rich countries sprint to immunise their populations and squabble over supplies, a second, equally vital, effort is getting under way: the race to vaccinate billions of people in the developing world...

This article is reserved for Sunday Times Daily subscribers.
A subscription gives you full digital access to all Sunday Times Daily content.

Sunday Times Daily

Already subscribed? Simply sign in below.

Questions or problems?
Email or call 0860 52 52 00.